The longitudinal associations between cognition, mood and striatal dopaminergic binding in Parkinson's Disease

被引:18
作者
Bayram, Ece [1 ]
Kaplan, Nikki [2 ]
Shan, Guogen [3 ]
Caldwell, Jessica Z. K. [2 ]
机构
[1] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
[2] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA
[3] Univ Nevada, Dept Environm & Occupat Hlth, Las Vegas, NV 89154 USA
关键词
Parkinson's disease; cognition; mood; striatum; dopamine; POSITRON-EMISSION-TOMOGRAPHY; ANXIETY; SYMPTOMS; AVAILABILITY; PROGRESSION; DEPRESSION; SYSTEM; SPECT;
D O I
10.1080/13825585.2019.1653445
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Cognitive decline and mood symptoms are common in Parkinson's disease (PD). Reductions in striatal dopaminergic binding have been associated with worse cognition and mood. We investigated whether this association persists throughout the disease progression in newly diagnosed PD. Four-year data from Parkinson's Progression Markers Initiative (PPMI) were used. Groups consisted of left and right limb dominantly affected PD patients, and controls. Longitudinal relationships between cognition, mood and striatal binding ratios were assessed by repeated measures correlations. Reduced binding was associated with general cognitive decline in controls, reduced processing speed and increased mood symptoms in PD. Anxiety was associated with striatum only in left limb dominantly affected PD. Dominantly affected limb side did not impact striatum and cognition association. There are longitudinal associations between striatum, processing speed and anxiety. Dopamine transporter availability imaging may have some prognostic value for cognition and mood in PD.
引用
收藏
页码:581 / 594
页数:14
相关论文
共 35 条
[1]   Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study [J].
Aarsland, D ;
Andersen, K ;
Larsen, JP ;
Lolk, A ;
Kragh-Sorensen, P .
ARCHIVES OF NEUROLOGY, 2003, 60 (03) :387-392
[2]   Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes [J].
Bajaj, Nin ;
Hauser, Robert A. ;
Grachev, Igor D. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11) :1288-1295
[3]   Neurotransmission in Parkinson's disease: beyond dopamine [J].
Barone, P. .
EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (03) :364-376
[4]   [123I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis [J].
Brigo, F. ;
Matinella, A. ;
Erro, R. ;
Tinazzi, M. .
EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (11) :1369-+
[5]   Clinical Markers of Anxiety Subtypes in Parkinson Disease [J].
Broen, Martinus P. G. ;
Leentjens, A. F. G. ;
Hinkle, J. T. ;
Moonen, A. J. H. ;
Kuijf, M. L. ;
Fischer, N. M. ;
Perepezko, K. ;
Bakker, A. ;
Pontone, G. M. .
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2018, 31 (02) :55-62
[6]   Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus [J].
Brück, A ;
Portin, R ;
Lindell, A ;
Laihinen, A ;
Bergman, J ;
Haaparanta, M ;
Solin, O ;
Rinne, JO .
NEUROSCIENCE LETTERS, 2001, 311 (02) :81-84
[7]   Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease [J].
Caspell-Garcia, Chelsea ;
Simuni, Tanya ;
Tosun-Turgut, Duygu ;
Wu, I-Wei ;
Zhang, Yu ;
Nalls, Mike ;
Singleton, Andrew ;
Shaw, Leslie A. ;
Kang, Ju-Hee ;
Trojanowski, John Q. ;
Siderowf, Andrew ;
Coffey, Christopher ;
Lasch, Shirley ;
Aarsland, Dag ;
Burn, David ;
Chahine, Lana M. ;
Espay, Alberto J. ;
Foster, Eric D. ;
Hawkins, Keith A. ;
Litvan, Irene ;
Richard, Irene ;
Weintraub, Daniel .
PLOS ONE, 2017, 12 (05)
[8]   Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease [J].
Chung, Seok Jong ;
Yoo, Han Soo ;
Oh, Jungsu S. ;
Kim, Jae Seung ;
Ye, Byoung Seok ;
Sohn, Young H. ;
Lee, Phil Hyu .
PARKINSONISM & RELATED DISORDERS, 2018, 51 :43-48
[9]   Molecular imaging of the dopaminergic system and its association with human cognitive function [J].
Cropley, VL ;
Fujita, M ;
Innis, RB ;
Nathan, PJ .
BIOLOGICAL PSYCHIATRY, 2006, 59 (10) :898-907
[10]   DaTscan and Parkinson's disease: DAT binding should not lead to binding decisions in clinical practice [J].
de la Fuente-Fernandez, R. ;
Loevblad, K. -O. .
EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (11) :1351-1352